We think of Alzheimer’s Disease and dementia as a disease effecting older individuals. However, diagnosis rates of early-onset dementia and Alzheimer’s disease tripled between 2013 and 2017, according to a new study. Early-onset dementia and Alzheimer’s Disease jumped 200% among commercially insured Americans between the ages of 30 and 64 over a recent five-year period, a new analysis of Blue Cross and Blue Shield health insurer claims shows.
“The increase in early-onset dementia and Alzheimer’s diagnoses among a generation who typically wouldn’t expect to encounter these conditions for several decades is concerning, especially since there is no cure for Alzheimer’s disease,” said Dr. Vincent Nelson, vice president of medical affairs for the Blue Cross Blue Shield Association, which gathered data for the report from a database of medical claims of more than 48 million commercially insured Blue Cross customers.
What is the cause of this recent trend and what are the implications for future care? These are important issues that will need to be addressed. You can read the Blue Cross report at the below link.